Chemotactic activity in inflammatory bowel disease: Role of leukotriene B4
The DOI matches its Crossref record; 32 of the 32 references it cites were found in a registry or an index.
Abstract
An important histologic feature of inflammatory bowel disease (IBD) is infiltration of the colonic mucosa with neutrophils. To investigate the nature of the chemotactic agents responsible for this infiltration, colonic mucosa from three normals and nine patients with inflammatory bowel disease (seven ulcerative colitis, two Crohn's colitis) was assayed for chemotactic activity for human neutrophils in vitro in a Boyden chamber. There was more (greater than 10-fold more) chemotactic activity in homogenates of inflammatory bowel disease mucosa than in homogenates of normal colonic mucosa. Analysis of the chemotactic activity in the inflammatory bowel disease mucosa revealed that most was lipid extractable. Moreover, when the lipid extract was fractionated by reverse-phase high-pressure liquid chromatography, the only fraction with significant chemotactic activity was the fraction that coeluted with leukotriene B4. The chemotactic response to IBD mucosa was blocked by anti-LTB4 antisera. The amount of chemotactic activity in lipid extracts of different inflammatory bowel disease specimens correlated well with the concentration of leukotriene B4 measured by UV absorbance (250 ng/g of mucosa). These data suggest that leukotriene B4 is an important stimulus to neutrophil chemotaxis in inflammatory bowel disease and, thus, may play a major role in the amplification of the inflammatory response in this condition.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“that mediate immune cell recruitment (44,45)”
From Contributions of microbiome and mechanical deformation to intestinal bacterial overgrowth and inflammation in a human gut-on-a-chip (2016) · cites this paper as [44]
Citations
Cites
Ford-Hutchinson, A. W., Bray, M. A., Doig, M. V., Shipley, M. E., & Smith, M. J. H. (1980) · Nature · doi:10.1038/286264a0 · Cited by 2,060
Quantitative assay for acute intestinal inflammation based on myeloperoxidase activity
Krawisz, J. E., Sharon, P., & Stenson, W. F. (1984) · Gastroenterology · doi:10.1016/0016-5085(84)90202-6 · Cited by 1,758
Dahlén, S. E., Björk, J., Hedqvist, P., Arfors, K. E., Hammarström, S., Lindgren, J. A., & Samuelsson, B. (1981) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.78.6.3887 · Cited by 1,019
N-formylmethionyl peptides as chemoattractants for leucocytes.
Schiffmann, E., Corcoran, B. A., & Wahl, S. M. (1975) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.72.3.1059 · Cited by 881
Enhanced synthesis of leukotriene B4 by colonic mucosa in inflammatory bowel disease
Sharon, P., & Stenson, W. F. (1984) · Gastroenterology · doi:10.1016/s0016-5085(84)80015-3 · Cited by 738
Self-citationBorgeat, P., & Samuelsson, B. (1979) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)30120-5 · Cited by 648
The importance of phospholipase-A2 in prostaglandin biosynthesis
Flower, R. J., & Blackwell, G. J. (1976) · Biochemical Pharmacology · doi:10.1016/0006-2952(76)90216-1 · Cited by 642
Sharon, P., Ligumsky, M., Rachmilewitz, D., & Zor, U. (1978) · PubMed · Cited by 451
Research works printed but not linked: 2
- Lauritsen K, Laursen LS, Bukhave K, Rask-Madsen J: Effects of systemic prednisolone on arachidonic acid metabolites determined by equilibriumin vivo dialysis of rectum in severe relapsing ulcerative colitis. Gastroenterology 88:1466, 1985 (abstract)
- Peskar BM, Dreyling KW, Hoppe U, Schaarschmidt K, Goebell H, Peskar BA: Formation of sulfidopeptide-leukotrienes (SP-LT) in normal human colonic tissue, colonic carcinoma, and Crohn's disease. Gastroenterology 88:1537, 1985 (abstract)
Cited by
Items 101–144 of 144
Lee, Y., Lee, J., & Ju, J. (2019) · Food Science and Biotechnology · doi:10.1007/s10068-019-00711-8 · Cited by 14
Schmidt, C., Fels, T., Baumeister, B., & Vetter, H. (1996) · Current Medical Research and Opinion · doi:10.1185/03007999609111561 · Cited by 14
Blockade of LTB4/BLT1 pathway improves CD8+ T-cell-mediated colitis
Nancey, S., Boschetti, G., Hacini‐Rachinel, F., Sardi, F., Durand, P.-Y., Borgne, M. L., Furhmann, L., Flourié, B., & Kaiserlian, D. (2010) · Inflammatory Bowel Diseases · doi:10.1002/ibd.21404 · Cited by 12
DISTRIBUTION AND ANTI‐INFLAMMATORY EFFECT OF MESALAZINE ON CARRAGEENAN‐INDUCED COLITIS IN THE RABBIT
Kitano, A., Matsumoto, T., Oshitani, N., Nakagawa, M., Yasuda, K., Watanabe, Y., Tomobuchi, M., Ōbayashi, M., Tabata, A., Fukushima, R., et al. (1996) · Clinical and Experimental Pharmacology and Physiology · doi:10.1111/j.1440-1681.1996.tb02828.x · Cited by 12
Platelet-activating factor and inflammatory bowel disease
Stenson, W. F. (1988) · Gastroenterology · doi:10.1016/0016-5085(88)90383-6 · Cited by 12
Tholander, F., Roques, B. P., Fournié‐Zaluski, M., Thunnissen, M. M. G. M., & Haeggström, J. Z. (2010) · FEBS Letters · doi:10.1016/j.febslet.2010.06.044 · Cited by 12
“, rheumatoid arthritis [7], inflammatory bowel disease [8] and psoriasis [9].”
Inhibition of leukotriene B4 production in murine macrophages by lactic acid bacteria
Kimoto‐Nira, H., Suzuki, C., Kobayashi, M., Sasaki, K., & Mizumachi, K. (2009) · International Journal of Food Microbiology · doi:10.1016/j.ijfoodmicro.2008.12.023 · Cited by 11
Hyperthermia prevents functional, histological and biochemical abnormalities induced during ileitis
Goldhill, Stojadinovic, A., KIANG, SMALLRIDGE, & Donohue (1999) · Neurogastroenterology & Motility · doi:10.1046/j.1365-2982.1999.00130.x · Cited by 11
Hirayama, M., Toda, R., Ozaki, T., Hasegawa, J., Nakamura, T., Naraki, Y., 原口紫, Hori, Y., Tanaka, T., Takei, M., et al. (2011) · Molecular Pharmaceutics · doi:10.1021/mp200088z · Cited by 9
Yagita, A., Sukegawa, Y., Maruyama, S., Sato, N. A., Atomi, Y., Yamaguchi, H., Kamiya, S., Ihara, T., & Sugamata, M. (1999) · Digestive Diseases and Sciences · doi:10.1023/a:1026691525874 · Cited by 10
Kimura, I., Nagahama, S., KAWASAKI, M., Kataoka, M., & Sato, M. (1996) · Folia Pharmacologica Japonica · doi:10.1254/fpj.108.259 · Cited by 9
Chawla, A., Karl, P. I., & Fisher, S. E. (1995) · Journal of the American College of Nutrition · doi:10.1080/07315724.1995.10718505 · Cited by 8
McCarty, M. F. (1998) · Medical Hypotheses · doi:10.1016/s0306-9877(98)90247-x · Cited by 8
Baumeister, B., Schmidt, C., Helisch, A., & Kipnowski, J. (1996) · Journal of Clinical Gastroenterology · doi:10.1097/00004836-199603000-00009 · Cited by 9
Acid Treatment Increased Leukotriene B4 in The Red Alga, Gracilaria asiatica (=verrucosa)
Sajiki, J. (1999) · Fisheries Science · doi:10.2331/fishsci.65.914 · Cited by 8
Salicylates for inflammatory bowel disease
Travis, S. P. L., & Jewell, D. P. (1994) · Baillière s Clinical Gastroenterology · doi:10.1016/0950-3528(94)90002-7 · Cited by 7
Prostaglandin E2 localization in the rat ileum
Schmauder-Chock, E. A., & Chock, S. P. (1992) · The Histochemical Journal · doi:10.1007/bf01047587 · Cited by 5
Treatment of inflammatory bowel disease from now to the millennium
COLE, A. T., & Hawkey, C. J. (1994) · Baillière s Clinical Gastroenterology · doi:10.1016/0950-3528(94)90009-4 · Cited by 4
Masoumi‐Ardakani, Y., Abbasnejad, M., Derakhshanfar, A., Bezenjani, K. E. P., & Mostafavi, A. (2010) · Cited by 4
Inflammatory Bowel Disease: The Asthma of the Intestine?
Eliakim, R., & Rachmilewitz, D. (1996) · Inflammatory Bowel Diseases · doi:10.1002/ibd.3780020210 · Cited by 4
Inhibitors of Fatty Acid-Derived Mediators
Hay, D. W. P., & Griswold, D. E. (1994) · Elsevier eBooks · doi:10.1016/b978-0-12-198875-3.50011-6 · Cited by 4
5-aminosalicylic acid preparations in the treatment of inflammatory bowel disease
Bonner, G. F., & Ruderman, W. B. (1993) · Inflammopharmacology · doi:10.1007/bf02660616 · Cited by 3
Farokhi, S., Bahrami, G., Babaie, A., & Farzaei, M. (2019) · Journal of Medicinal Plants · doi:10.29252/jmp.4.72.135 · Cited by 3
Wallace, J. L. (2000) · Humana Press eBooks · doi:10.1007/978-1-59259-202-9_1 · Cited by 3
Welche Rolle spielt die ernährung bei der colitis ulcerosa?
Bartels, M., Nagel, E., & Pichlmayr, R. (1995) · Langenbeck s Archives of Surgery · doi:10.1007/bf00184410 · Cited by 3
Potential and Therapeutic Value of Development of Novel 5-Lipoxygenase Inhibitors
Ford‐Hutchinson, A. W. (1991) · Elsevier eBooks · doi:10.1016/b978-0-12-197800-6.50010-x · Cited by 3
Pharmacokinetics and pharmacodynamics of fenleuton, a 5-lipoxygenase inhibitor, in ponies
Marr, K. A., Marsh, K. C., Hernandez, L. E., Cunningham, F. M., & Lees, P. (1998) · Research in Veterinary Science · doi:10.1016/s0034-5288(98)90005-4 · Cited by 3
Immunopharmacology of Eicosanoids in the Gastrointestinal Tract
Wallace, J. L. (1993) · Elsevier eBooks · doi:10.1016/b978-0-12-732860-7.50015-0 · Cited by 2
Cardoso, C. R. D. B., Habka, A. D. C., Pinzan, C. F., Oliveira, C. N. S., da Silva, J. L., & Duarte-Silva, M. (2019) · IntechOpen eBooks · doi:10.5772/intechopen.90009 · Cited by 7
Jackson, W. T., & Fleisch, J. H. (1996) · Birkhäuser Basel eBooks · doi:10.1007/978-3-0348-8996-4_3 · Cited by 2
Peskar, B. M. (1988) · Journal of Molecular Medicine · doi:10.1007/bf01727854 · Cited by 2
“Lobos und Mitarbeiter [9] haben vor kurzem gezeigt, dab intestinale Mucosa eine chemotaktisch wirksame Aktivitfit zu bilden vermag.”
BackgroundIchak yalligʻlanishida immunitetning ahamiyati
Yusupovna, M. I. (2022) · Eurasian Journal of Medical and Natural Sciences · doi:10.70413/ejmns-v02-i05-p1-029 · Cited by 1
Inflammatory Bowel Disease: Treatment Modalities and Mucosal Prostaglandin/Leukotriene Formation
Sharon, P. (1988) · Springer eBooks · doi:10.1007/978-3-642-73316-1_55 · Cited by 1
Therapie chronisch-entzündlicher Darmerkrankungen
Peskar, B. M. (1990) · Verhandlungen der Deutschen Gesellschaft für Innere Medizin · doi:10.1007/978-3-642-84317-4_140 · Cited by 1
Immunologische Aspekte bei Morbus Crohn
Auer, I. O. (1989) · Springer eBooks · doi:10.1007/978-3-642-75075-5_5 · Cited by 1
Leukotrienes in Human and Experimental Ulcerative Colitis
Wallace, J. L., Morris, G. P., & Keenan, C. M. (1995) · Springer eBooks · doi:10.1007/978-1-4615-1867-9_9
Catalytic mechanisms and evolution of leukotriene A4 hydrolyse
Tholander, F. (2006) · Figshare
Lauritsen, K., Laursen, L., Kjeldsen, J., Bukhave, K., & Rask-Madsen, J. (1993) · Inflammopharmacology · doi:10.1007/bf02660615
Holistic Approach in Cases of irritable Bowel Syndrome
Alp, H. (2021) · Gastroenterology Pancreatology and Hepatobilary Disorders · doi:10.31579/2641-5194/034
Tholander, F., Wetterholm, A., & Haeggström, J. Z. (2004) · Springer eBooks · doi:10.1007/978-1-4419-8869-0_5
Choi, H. S., Kim, D., Jang, Y.-J., Moon, J. S., & Oh, I. (2024) · Food Supplements and Biomaterials for Health · doi:10.52361/fsbh.2024.4.e3
Immunophysiology of Intestinal Electrolyte Transport
Powell, D. W. (1991) · Comprehensive physiology · doi:10.1002/j.2040-4603.1991.tb01423.x · Cited by 29
BindingDB (2012) · UC San Diego · doi:10.7270/q2xd1066
Metadata
- Authors
- Lobos, E. A., Sharon, P., & Stenson, W. F.
- Affiliations
- Washington University in St. Louis (US)
- Venue
- Digestive Diseases and Sciences
- Published
- 1987-12
- Volume
- 32
- Issue
- 12
- Pages
- 1380-1388
- ISSN
- 0163-2116 (ISSN-L)
- 1573-2568
- OpenAlex
- W2322570099
- Cited by
- 143
- References
- 32
- Citations by year
- 2024: 1 · 2023: 1 · 2022: 2 · 2021: 1 · 2020: 2 · 2019: 3 · 2018: 1 · 2016: 3 · 2015: 1 · 2013: 1
- FWCI
- 3.22
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Digestive Diseases and Sciences (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health (5r01am033165-02)
- Topics
- Health Sciences › Medicine › Gastroenterology › Inflammatory Bowel Disease
- Health Sciences › Medicine › Pharmacology (medical) › Inflammatory mediators and NSAID effects
- Health Sciences › Medicine › Ophthalmology › Ocular Diseases and Behçet’s Syndrome
- Keywords
- inflammatory bowel disease, neutrophil chemotaxis, leukotriene B4, colonic mucosa, ulcerative colitis, Crohn's disease, mucosal inflammation
- MeSH terms
- Adult, Chemotactic Factors, Chemotaxis, Leukocyte, Chromatography, High Pressure Liquid, Colitis, Ulcerative, Crohn Disease, Female, Humans, Intestinal Mucosa, Leukotriene B4, Male, Middle Aged, Neutrophils
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.